Braemar Energy Ventures, which has offices in New York and Boston, plans to raise $300 million for a new fund, according to an SEC filing. Braemar focuses on energy technology and is invested in more than 25 companies in the fields of oil and gas, lighting, solar, clean coal, biofuels, smart grid, and more. Its current investments include South San Francisco-based Solazyme, a company that’s making clean energy from algae and other marine microorganisms and that recently filed for an initial public offering.
Author: Arlene Weintraub
Arlene is an award-winning journalist specializing in life sciences and technology. She was previously a senior health writer based out of the New York City headquarters of BusinessWeek, where she wrote hundreds of articles that explored both the science and business of health. Her freelance pieces have been published in USA Today, US News & World Report, Technology Review, and other media outlets. Arlene has won awards from the New York Press Club, the Association of Health Care Journalists, the Foundation for Biomedical Research, and the American Society of Business Publication Editors. Her book about the anti-aging industry, Selling the Fountain of Youth, was published by Basic Books in September 2010.
View all posts by Arlene Weintraub
